New diabetes drug tested in everyday clinics
Disease control
Recruiting now
This study is observing 300 adults with type 2 diabetes who are already taking luseogliflozin as part of their routine care. Researchers will track changes in blood sugar levels, body weight, and side effects over time. The goal is to see how well the drug works in real-world set…
Sponsor: Servier Russia • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC